Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.

Illumina, Inc. (NASDAQ: ILMN), a global leader in next-generation sequencing and array-based technologies, today announced a collaboration with Broad Clinical Labs to rapidly streamline and scale ...

Illumina is one of Mainboard-listed Venture Corporation’s major customers. Illumina’s shares have fallen some 26.4% over the ...

New Delhi: The escalating US-China tariff war has ratcheted up to enter the field of biotechnology and science. For the first ...

The costs of genomic sequencing have fallen very rapidly for the past decade and will continue to do so. As it becomes less ...

Set for release in 2026, the ‘first-of-its-kind’ technology aims to give researchers the ability to analyse more cells in a ...

The DNA Sequencing Industry has rapidly transformed into one of the most crucial areas of biotechnology. What was once a time ...

Illumina unveils first-of-its-kind spatial transcriptomics technology: San Diego Friday, February 21, 2025, 17:00 Hrs [IST] Illumina, Inc. announced a new spatial technology progr ...

Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers explore cellular behavior mapped across complex tissues. | The company said ...

BEIJING’S surprise move to blacklist Illumina has unleashed a frenzy among the US firm’s Chinese rivals to win market share ...

The "most promising areas" are integrated device manufacturers (IDMs) and high-end outsourced assembly and test (OSAT) ...